Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM1A | O60341 | 1/20 | 0.40 |
| ▸ | POLB | P06746 | 2/20 | 0.39 |
| ▸ | MEN1 | O00255 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.39 |
| ▸ | GAA | P10253 | 1/20 | 0.38 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | PKM | P14618 | 1/20 | 0.36 |
| ▸ | TSHR | P16473 | 1/20 | 0.36 |
| ▸ | PPARG | P37231 | 1/20 | 0.36 |
| ▸ | GSK3B | P49841 | 3/20 | 0.35 |
| ▸ | Q9HBH1 | 1/20 | 0.35 | |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26049380 | 0.91 | GAA (0.47) | POLBGAAL3MBTL1ALDH1A1PKM | |
| SCHEMBL24228679 | 0.86 | CYP3A4 (0.45) | POLBMEN1KMT2AGAAALDH1A1 | |
| SCHEMBL24228688 | 0.85 | GSK3B (0.35) | GSK3B | |
| SCHEMBL26049194 | 0.85 | GSK3B (0.35) | GSK3B | |
| SCHEMBL24228687 | 0.85 | GSK3B (0.35) | GAAL3MBTL1GSK3B | |
| SCHEMBL30445676 | 0.85 | GSK3B (0.35) | GAAL3MBTL1GSK3B | |
| SCHEMBL29373153 | 0.85 | GSK3B (0.35) | GSK3B | |
| SCHEMBL6313787 | 0.80 | KDM1A (0.43) | KDM1APOLBL3MBTL1ALDH1A1PKM | |
| SCHEMBL15493920 | 0.76 | KDM1A (0.40) | KDM1APOLBALDH1A1PKMTSHR | |
| SCHEMBL30986852 | 0.75 | MAOA (0.41) | ALDH1A1GSK3B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2022023439-A1 | RADIOLABELED COMPOUNDS | KING'S COLLEGE LONDON (GB) | 2022-02-03 | — | — | WO | disclosed |